Viking Therapeutics Inc (VKTX)

[ZeWaffleBaron]

Hey Greens! There are just so many potential directions to go. I think they are waiting on a partner to direct the main focus and the trial design, and am guessing they will let the FDA guide them with the easiest possible path to getting it to market, and then probably launch a bunch of these ‘niche’ indication trials, to allow for expanded use for other conditions like stress incontinence etc, or at least to give docs a clue that it might have some off label uses. It would be a lot of backtracking and require a lot of proof of concept stuff to approach niche stuff like urinary stress at this stage of the game. I think there are a lot of ‘less bumpy’ roads to FDA clearing the drug itself to some sort of market along the fracture pathways and mobility pathways with healing and debilitation. Long term, the future is bright if they can keep the ball rolling with all these other possible indications, but a lot of road to cover between now and then.

Patiently awaiting MDGL’s data, like all other faithful Viking’s, hoping it gives us a boost that can be followed shortly after by an end of enrollment update. Wishful thinking of course, but time has been flying by, it’s got to come eventually.

Take care buddy